The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
RationaleBrain dopamine (DA) participates in the modulation of instrumental behavior, including aspects of behavioral activation and effort-related choice behavior. Rats with impaired DA transmission reallocate their behavior away from food-seeking behaviors that have high response requirements, and instead select less effortful alternatives. Although accumbens DA is considered a critical component of the brain circuitry regulating effort-related choice behavior, emerging evidence demonstrates a role for adenosine A2A receptors.ObjectiveAdenosine A2A receptor antagonism has been shown to reverse the effects of DA antagonism. The present experiments were conducted to determine if this effect was dependent upon the subtype of DA receptor that was antagonized to produce the changes in effort-related choice.Materials and methodsThe adenosine A2A receptor antagonist MSX-3 (0.5–2.0 mg/kg IP) was assessed for its ability to reverse the effects of the D1 family antagonist SCH39166 (ecopipam; 0.2 mg/kg IP) and the D2 family antagonist eticlopride (0.08 mg/kg IP), using a concurrent lever pressing/chow feeding procedure.ResultsMSX-3 produced a substantial dose-related reversal of the effects of eticlopride on lever pressing and chow intake. At the highest dose of MSX-3, there was a complete reversal of the effects of eticlopride on lever pressing. In contrast, MSX-3 produced only a minimal attenuation of the effects of SCH39166, as measured by regression and effect size analyses.ConclusionsThe greater ability of MSX-3 to reverse the effects of D2 vs. D1 blockade may be related to the colocalization of D2 and adenosine A2A receptors on the same population of striatal neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tonic dopamine: Opportunity costs and the control of response vigor
Niv, Y., Daw, N. D., Joel, D., & Dayan, P. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0502-4 · Cited by 1,133 · cited 2×
“…behavioral activation, instrumental response output, response allocation, effort-related processes; Salamone et al. 1991, 1997, 2002, 2003, 2005, 2007; Kelley et al. 2005; Baldo and Kelley 2007; Barbano and Cador 2007; Niv et al. 2007; Phillips et al. 2007; Floresco et al. 2008; Sink et al. 2008).”
BackgroundResultSalamone, J. D., & Correa, M. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00282-6 · Cited by 817
Self-citationAmygdala-prefrontal cortical circuitry regulates effort based decision making
Floresco, S. B., & Ghods-Sharifi, S. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj143 · Cited by 316 · cited 1×
“In addition to nucleus accumbens DA, other brain areas and transmitters are involved in effortrelated processes, including prefrontal cortex, amygdala, and ventral pallidum (Walton et al. 2002, 2003, 2006; Denk et al. 2005; Schweimer et al. 2005; Schweimer and Hauber 2006; Floresco and Ghods-Sharifi 2007; Floresco et…”
BackgroundSalamone, J. D. (1992) · Psychopharmacology · doi:10.1007/bf02245133 · Cited by 291
Self-citationThe many faces of fatigue in major depressive disorder
Demyttenaere, K., De Fruyt, J., & Stahl, S. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004729 · Cited by 288 · cited 2×
“M. Shahriari University of Connecticut Health Center, Farmington, CT, USA Stahl 2002; Demyttenaere et al. 2005; Salamone et al. 2006, 2007; Yurgelun-Todd et al. 2007; Capuron et al. 2007; Majer et al. 2008).”
BackgroundAberman, J. E., & Salamone, J. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00004-4 · Cited by 263 · cited 2×
“Rats with nucleus accumbens DA depletions are very sensitive to ratio requirements in operant schedules (Sokolowski and Salamone 1998; Aberman and Salamone 1999; Correa et al. 2002; Mingote et al. 2005) and show alterations in response allocation in tasks that measure effort-related choice behavior…”
BackgroundSelf-citationCousins, M. S., Atherton, A., Turner, L., & Salamone, J. D. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00151-4 · Cited by 236 · cited 2×
“Several studies in this area have employed maze tasks to assess effort-related choice (Salamone et al. 1994; Cousins et al. 1996; Floresco et al. 2008), while others have used a concurrent fixed ratio 5 (FR5)/chow feeding procedure (Salamone et al.”
MethodSelf-citationBasal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301362 · Cited by 229 · cited 2×
“M. Shahriari University of Connecticut Health Center, Farmington, CT, USA Stahl 2002; Demyttenaere et al. 2005; Salamone et al. 2006, 2007; Yurgelun-Todd et al. 2007; Capuron et al. 2007; Majer et al. 2008).”
BackgroundAdenosine A1-A2A receptor heteromers: New targets for caffeine in the brain
Ferre, S. (2008) · Frontiers in bioscience · doi:10.2741/2852 · Cited by 149 · cited 2×
“Thus, it is possible that MSX-3 was easily able to produce a robust reversal of the effects of eticlopride because adenosine A2A receptors and D2 receptors are localized on the same neurons (i.e., enkephalin positive medium spiny neurons), and these receptors interact directly either because of heterodimerization or c…”
BackgroundMajer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.009 · Cited by 124
Cited by
Treadway, M. T., Buckholtz, J. W., Schwartzman, A. N., Lambert, W. E., & Zald, D. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006598 · Cited by 769
International society of sports nutrition position stand: caffeine and performance
Goldstein, E. R., Ziegenfuss, T., Kalman, D., Kreider, R., Campbell, B., Wilborn, C., Taylor, L., Willoughby, D., Stout, J., Graves, B. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-5 · Cited by 686
International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance
Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665
Recent developments in adenosine receptor ligands and their potential as novel drugs
Müller, C. E., & Jacobson, K. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.017 · Cited by 431
Self-citationPurinergic signalling: From normal behaviour to pathological brain function
Burnstock, G., Krügel, U., Abbracchio, M. P., & Illes, P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.006 · Cited by 397
Metadata
- Authors
- Worden, L. T., Shahriari, M., Farrar, A. M., Sink, K. S., Hockemeyer, J., Müller, C. E., & Salamone, J. D.
- Venue
- Psychopharmacology
- Published
- 2008-12-02
- Volume
- 203
- Issue
- 3
- Pages
- 489-499
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2093679869
- Cited by
- 78
- References
- 10
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. https://app.cochat.ai/papers/10.1007/s00213-008-1396-0
- The paper
- Worden, L. T., Shahriari, M., Farrar, A. M., Sink, K. S., Hockemeyer, J., Müller, C. E., & Salamone, J. D. (2009). The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology. https://doi.org/10.1007/s00213-008-1396-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.